Biotech Values

[DewDiligence]

PKI posts solid quarter, raises 4Q12 EPS guidance:

http://www.reuters.com/article/2012/10/25/perkinelmer-results-idUSL1E8LPE8R20121025

Excluding one-time items, the company earned 45 cents per share, just ahead of analysts' average estimate of 44 cents per share, according to Thomson Reuters I/B/E/S… Revenue rose 13 percent to $509.6 million.

For the full year, PerkinElmer raised its estimate for adjusted [i.e. non-GAAP] earnings per share to between $2.05 and $2.07 from its previous range of $2.00 to $2.05.

Since non-GAAP EPS for the first 9 months of 2012 was $1.41, PKI is now forecasting 4Q12 non-GAAP EPS of $0.59-0.64.

As previously noted, PKI is a strong beneficiary of The Global Demographic Tailwind. I’ll post additional info from the CC this evening if anything noteworthy comes up.